View drug registration information details.


ItemsRegistration information
ID97
No97
Brand NameBROMALEX
IngredientsBROMAZEPAM 6 MG
Dosage FormTABLET
Primary PackagingBLISTERPACK
StorageSTORE BELOW 30 C
Shelf Life3 YEARS
Pack SizeBOX OF 3 X 10'S
Dispensing CategoryPrescription only
ATC ClassificationN05BA08
Pharmaceutical ClassANXIOLYTIC
IndicationsSYMPTOMATIC TREATMENT OF SEVERE AND/OR DISABLING ANXIETY, PREVENTION AND TREATMENT OF DELIRIUM TREMENS AND OTHER MANIFESTATION OF ALCOHOL WITHDRAWAL
ContraindicationsALLERGY, SEVERE RESPIRATORY FAILURE, SLEEP APNEA SYNDROME, SEVERE LIVER DISEASE, MYASTHENIA
Side EffectsANGIOEDEMA, ANAPHYLACTIC SHOCK, CONFUSION STATE, AFFECTIVE DISORDER, DROWSINESS, HEADACHE, DIZZINESS, DIPLOPIA, HEART FAILURE, NAUSEA, VOMITTING, CONSTIPATION, RASH, PRURITUS, FATIGUE
Unit Price-
EDL Yes
DescriptionWHITE, OBLONG, BICONVEX TABLET, WITH THREE BREAKABLE LINES ON BOTH SIDES.
Note
License OwnerARAVANH PHARMA SOLE CO.,LTD
ManufacturerPHARMA PRODUCT MANUFACTURING (PPM)
CountryCAMBODIA
Import Registration NoCAM R2 0519LP-08
Import Registration Date2018-04-10
ActivityCERTIFICATE RELEASED
Applied Date2022-10-05
FDD Registration No08 I 4765/19
FDD Registration Date2023-04-19
Expiry Date2026-04-18

Back to drug list